Table 2.

Association between NAFLD and subclinical hypothyroidism (All data + TPO stratification).

	All		TPO (−)		TPO (+)
	OR (95% CI)	p-Value	OR (95% CI)	p-Value	OR (95% CI)	p-Value
Crude	1.42 (0.94–2.14)	0.093	1.43 (0.88–2.35)	0.151	0.87 (0.39–1.91)	0.723
Model 1	1.26 (0.76–2.09)	0.372	1.36 (0.73–2.55)	0.328	0.86 (0.38–1.92)	0.705
Model 2	1.26 (0.77–2.09)	0.359	1.37 (0.74–2.53)	0.312	0.84 (0.38–1.85)	0.658
Model 3	1.32 (0.78–2.22)	0.302	1.41 (0.74–2.68)	0.296	0.92 (0.41–2.09)	0.844
Model 4	1.32 (0.76–2.29)	0.325	1.47 (0.78–2.80)	0.236	0.91 (0.41–2.01)	0.810

Model 1; adjusted by age and sex.

Model 2; Model 1 + smoking, physical activity, and income.

Model 3; Model 2 + metabolic syndrome.

Model 4; Model 3 + urine iodine.

TPOAb, thyroid peroxidase antibodies.